TABLE 4.
Patient characteristics | Odds of completing treatment
|
Odds of achieving a SVR
|
||
---|---|---|---|---|
Adjusted odds ratio | P valueb | Adjusted odds ratio | P value | |
All genotypes | ||||
Major HCV genotype | ||||
1 or 4 | 1 | – | 1 | – |
2 or 3 | 1.75 (0.85, 3.58) | .13 | 2.09 (1.12. 3.90) | .02 |
Cirrhosis3 | ||||
No | 1 | – | 1 | – |
Yes | 0.16 (0.03, 0.81) | .03 | 0.31 (0.06, 1.46) | .14 |
Movement during treatment | ||||
None | 1 | – | 1 | – |
Transferred but not released | 0.41 (0.17, 1.00) | .05 | 0.58 (0.26, 1.27) | .18 |
Released (+/− transfer) | 0.10 (0.04, 0.24) | <.01 | 0.33 (0.15, 0.71) | <.01 |
| ||||
Genotype 1/4 | ||||
Cirrhosis3 | ||||
No | 1 | – | 1 | – |
Yes | 0.33 (0.19, 5.89) | .45 | 0.50 (0.29, 8.71) | .63 |
Movement during treatment | ||||
None | 1 | – | 1 | – |
Transferred but not released | 1.17 (0.30, 4.47) | .82 | 0.50 (0.16, 1.59) | .24 |
Released (+/− transfer) | 0.17 (0.05, 0.54) | <.01 | 0.25 (0.08, 0.78) | .02 |
| ||||
Genotype 2/3 | ||||
Cirrhosis3 | ||||
No | 1 | – | 1 | – |
Yes | 0.12 (0.01, 0.97) | .05 | 0.24 (0.04, 1.52) | .13 |
Movement during treatment | ||||
None | 1 | – | 1 | – |
Transferred but not released | 0.17 (0.05, 0.56) | <.01 | 0.66 (0.22, 1.99) | .46 |
Released (+/− transfer) | 0.06 (0.02, 0.23) | <.01 | 0.43 (0.14, 1.31) | .14 |
At the time of treatment commencement.
P values in bold type denote statistical significance at P <0.05.